Verseon Playing The Long Game To Level Up Drug Discovery
Executive Summary
Adityo Prakash, CEO and founder of Verseon, tells In Vivo more about his vision of re-routing the pharmaceutical industry with Verseon’s computational drug discovery technology. He also explains the company’s new subsidiary business, BlockRules, and how it fits into the biopharma world.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.